Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma

Frontiers in Oncology
Weiwei ShiChunping Jiang

Abstract

Background: Regorafenib is a second-line therapy drug used for advanced hepatocellular carcinoma (HCC). Unfortunately, the survival benefit of the patients receiving this treatment is modest, which may be attributed to drug resistance. In the present study, sphingosine kinase 2 (SphK2) was targeted to reverse regorafenib resistance in HCC. Methods: The functions of SphK2 and sphingosine-1-phosphate (S1P), the catalytic product of SphK2 in regorafenib resistance of HCC cells, were evaluated by cell counting kit-8 assay, colony formation, cell cycle evaluation, and annexin V-fluorescein isothiocyanate/propidium iodide double-staining assay. The antitumor activity of combined treatment of regorafenib and the SphK2-specific inhibitor ABC294640 was examined in HCC cells in vitro and xenograft model in vivo. The molecular mechanisms of SphK2/S1P-mediating regorafenib resistance were investigated using cell line establishment and Western blot analysis. Results: Well-developed regorafenib-resistant HCC cells indicated high expression levels of SphK2. The sensitivity to regorafenib of regorafenib-resistant HCC cells was restored following SphK2 knockdown or pharmacological inhibition by ABC294640. In addition, ectopic expression of SphK...Continue Reading

References

Apr 18, 2009·Molecular Cancer Therapeutics·Julie Guillermet-GuibertCorinne Bousquet
Jan 12, 2010·The Journal of Pharmacology and Experimental Therapeutics·Kevin J FrenchCharles D Smith
May 18, 2010·Investigational New Drugs·Vladimir BeljanskiCharles D Smith
Sep 24, 2010·Endocrinology·James W AntoonBarbara S Beckman
Mar 27, 2012·International Journal of Molecular Medicine·Cheol Woong JungSang Yong Choi
Sep 26, 2013·Nature Reviews. Cancer·Caitriona HolohanPatrick G Johnston
Jan 16, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Liang ZhangRupal S Bhatt
Aug 1, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Erlin SunRuifa Han
Oct 1, 2015·Journal of Cellular Physiology·Giovanna MironeGabriella Marfe
Dec 3, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Wei LiuLi Cai
May 10, 2017·Journal of Gastrointestinal Oncology·Dae Won KimRichard Kim
Jun 18, 2017·Science China. Life Sciences·Zuoquan XieMeiyu Geng
Oct 24, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Morris Sherman
Dec 27, 2017·International Journal of Cancer. Journal International Du Cancer·Lu DaiZhiqiang Qin
Mar 25, 2018·European Journal of Radiology·Carmen AyusoConcepción Brú
Jun 16, 2018·Molecular Cancer Research : MCR·Jung-Chien ChengPamela A Hoodless
Nov 21, 2018·Journal of Cellular Physiology·Leili HasanifardBahman Yousefi
Dec 5, 2019·Liver Cancer·Lorenza RimassaPhilippe Merle

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
flow cytometry
transfection
Xenograft
electrophoresis

Software Mentioned

FlowJo
GraphPad Prism
ImageJ
GraphPad
SPSS

Related Concepts

Related Feeds

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.